Abstract
Background
Inflammatory
and
immune
responses
in
the
brain
that
contribute
to
various
neuropsychiatric
disorders
may
begin
as
microglial
“priming”.
Interferon
(IFN)‐γ
is
known
cause
priming,
but
mechanism
unclear.
Methods
We
examined
effects
of
IFN‐γ
on
gene
expression,
activation,
inflammatory
activity
NLRP3
inflammasome
primary
microglia
brains
mice.
Results
Our
results
showed
treating
cultures
with
induced
a
hedgehog‐like
morphology
upregulated
markers
activation
(CD86,
CD11b)
pro‐inflammatory
molecules
(IL‐1β,
IL‐6,
TNF‐α,
iNOS),
while
downregulating
homeostasis
(CX3CR1,
CD200R1),
anti‐inflammatory
(MCR1,
Arg‐1)
neurotrophic
factors
(IGF‐1,
BDNF).
also
(NLRP3,
caspase‐1,
gasdermin
D,
IL‐18).
This
particular
transcriptional
profiling
makes
IFN‐γ‐primed
exaggerated
upon
lipopolysaccharide
(LPS)
stimulation.
The
level
NLRP3,
IL‐1β,
IL‐18,
TNF‐α
iNOS
treated
both
LPS
were
highest
than
either
one
alone.
Injecting
into
lateral
ventricle
mice
similar
morphological
functional
changes
hippocampal
cultures.
from
or
hippocampus
abolished
when
STAT1
was
inhibited
using
fludarabin.
alone
together
anxiety‐
depression‐like
behaviors
impaired
hippocampus‐dependent
spatial
memory;
these
mitigated
by
Conclusions
primes
activating
STAT1,
which
upregulates
genes
activate
inflammasome.
Inhibiting
IFN‐γ/STAT1
axis
be
way
treat
neurodegenerative
diseases
psychiatric
involve
priming.
General Psychiatry,
Journal Year:
2024,
Volume and Issue:
37(1), P. e101374 - e101374
Published: Feb. 1, 2024
The
gut
microbiota
is
a
complex
and
dynamic
ecosystem
known
as
the
‘second
brain’.
Composing
microbiota-gut-brain
axis,
its
metabolites
regulate
central
nervous
system
through
neural,
endocrine
immune
pathways
to
ensure
normal
functioning
of
organism,
tuning
individuals’
health
disease
status.
Short-chain
fatty
acids
(SCFAs),
main
bioactive
microbiota,
are
involved
in
several
neuropsychiatric
disorders,
including
depression.
SCFAs
have
essential
effects
on
each
component
axis
In
present
review,
roles
major
(acetate,
propionate
butyrate)
pathophysiology
depression
summarised
with
respect
chronic
cerebral
hypoperfusion,
neuroinflammation,
host
epigenome
neuroendocrine
alterations.
Concluding
remarks
biological
mechanisms
related
will
hopefully
address
clinical
value
microbiota-related
treatments
for
Journal of Neurochemistry,
Journal Year:
2024,
Volume and Issue:
168(5), P. 910 - 954
Published: Jan. 6, 2024
Although
we
have
learned
much
about
how
the
brain
fuels
its
functions
over
last
decades,
there
remains
still
to
discover
in
an
organ
that
is
so
complex.
This
article
lays
out
major
gaps
our
knowledge
of
interrelationships
between
metabolism
and
function,
including
biochemical,
cellular,
subcellular
aspects
functional
imaging
adult
brain,
as
well
during
development,
aging,
disease.
The
focus
on
unknowns
substrates
associated
transporters,
roles
insulin
lipid
droplets,
emerging
role
microglia,
mysteries
cofactor
signaling
molecule
NAD
Molecular Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Feb. 21, 2025
Abstract
Alzheimer’s
disease
(AD)
poses
a
growing
global
health
challenge
as
populations
age.
Recent
research
highlights
the
crucial
role
of
peripheral
immunity
in
AD
pathogenesis.
This
review
explores
how
blood-brain
barrier
disruption
allows
immune
cells
to
infiltrate
central
nervous
system
(CNS),
worsening
neuroinflammation
and
progression.
We
examine
recent
findings
on
interactions
between
CNS-resident
microglia,
forming
self-perpetuating
inflammatory
cycle
leading
neuronal
dysfunction.
Moreover,
this
emphasizes
developments
dysregulation
factors
from
both
periphery
CNS,
their
impact
With
ongoing
development
new
therapeutic
strategies,
underscores
importance
modulating
CNS
therapy.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(1), P. 884 - 884
Published: Jan. 3, 2023
Alzheimer’s
Disease
(AD)
is
the
most
common
cause
of
dementia,
having
a
remarkable
social
and
healthcare
burden
worldwide.
Amyloid
β
(Aβ)
protein
Tau
aggregates
are
disease
hallmarks
key
players
in
AD
pathogenesis.
However,
it
has
been
hypothesized
that
microglia
can
contribute
to
pathophysiology,
as
well.
Microglia
CNS-resident
immune
cells
belonging
myeloid
lineage
innate
arm
immunity.
Under
physiological
conditions,
constant
motion
order
carry
on
their
housekeeping
function,
they
maintain
an
anti-inflammatory,
quiescent
state,
with
low
expression
cytokines
no
phagocytic
activity.
Upon
various
stimuli
(debris,
ATP,
misfolded
proteins,
pathogens),
acquire
function
overexpress
cytokine
gene
modules.
This
process
generally
regarded
activation
implies
production
pro-inflammatory
counterbalanced
by
synthesis
release
anti-inflammatory
molecules.
mechanism
avoids
excessive
inflammatory
response
inappropriate
microglial
activation,
which
causes
tissue
damage
brain
homeostasis
impairment.
Once
pathogenic
stimulus
cleared,
activated
return
naïve,
state.
repeated
(as
case
Aβ
deposition
early
stage
AD),
shift
toward
less
protective,
neurotoxic
phenotype,
known
“primed”
microglia.
The
main
characteristic
primed
lower
capability
turn
back
makes
these
prone
chronic
favours
inflammation
brain.
Primed
have
impaired
defence
capacity
against
injury
detrimental
effects
microenvironment.
Additionally,
priming
associated
onset
progression
represent
promising
target
for
treatment
strategies.
Many
factors
(genetics,
environmental
factors,
baseline
status
microglia,
ageing)
generate
aberrantly
phenotype
undergoes
easier
earlier
than
normally
do.
Novel,
targets
therapeutic
strategies
sought
field
and,
importantly,
among
those
influencing
cells.
CX3CL1
pathway
could
be
valuable
approach
AD,
although
preliminary
findings
from
studies
this
controversial.
current
review
aims
summarize
state
art
role
dysfunction
pathogenesis
proposes
biochemical
pathways
possible
treatment.
ACR Open Rheumatology,
Journal Year:
2024,
Volume and Issue:
6(6), P. 334 - 346
Published: April 25, 2024
Despite
being
some
of
the
most
anecdotally
well-known
roads
to
pathogenesis,
mechanisms
governing
autoimmune
rheumatic
diseases
are
not
yet
fully
understood.
The
overactivation
cellular
immune
system
and
characteristic
development
autoantibodies
have
been
linked
oxidative
stress.
Typical
clinical
manifestations,
such
as
joint
swelling
deformities
inflammation
skin
internal
organs,
also
connected
directly
or
indirectly
redox
mechanisms.
differences
in
generation
restraint
stress
provide
compelling
evidence
for
broad
variety
pathology
among
explain
common
triggers
discordant
manifestations
these
diseases.
Growing
pathogenesis
has
provided
a
array
new
potential
therapeutic
targets.
Here,
we
explore
by
which
is
generated,
its
roles
autoimmunity
end-organ
damage,
discuss
how
individual
exhibit
unique
features
that
offer
targets
interventions.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: June 22, 2024
Abstract
Microglia,
brain-resident
macrophages,
can
acquire
distinct
functional
phenotypes,
which
are
supported
by
differential
reprogramming
of
cell
metabolism.
These
adaptations
include
remodeling
in
glycolytic
and
mitochondrial
metabolic
fluxes,
potentially
altering
energy
substrate
availability
at
the
tissue
level.
This
phenomenon
may
be
highly
relevant
brain,
where
metabolism
must
precisely
regulated
to
maintain
appropriate
neuronal
excitability
synaptic
transmission.
Direct
evidence
that
microglia
impact
on
has
been
widely
lacking,
however.
Combining
molecular
profiling,
electrophysiology,
oxygen
microsensor
recordings
mathematical
modeling,
we
investigated
microglia-mediated
disturbances
brain
energetics
during
neuroinflammation.
Our
results
suggest
proinflammatory
showing
enhanced
nitric
oxide
release
decreased
CX3CR1
expression
transiently
increase
lactate/glucose
ratio
depends
transcriptional
microglia,
not
neurons.
In
this
condition,
network
activity
such
as
gamma
oscillations
(30–70
Hz)
fueled
increased
ATP
production
mitochondria,
is
reflected
elevated
consumption.
During
dysregulated
inflammation,
high
demand
low
glucose
boundary
conditions
for
fitness
revealed
kinetic
modeling
single
neuron
energetics.
Collectively,
these
findings
indicate
flexibility
protects
function
against
alterations
local
moderate
Cells,
Journal Year:
2023,
Volume and Issue:
12(8), P. 1207 - 1207
Published: April 21, 2023
Alzheimer’s
disease
(AD)
is
the
most
prevalent
neurodegenerative
worldwide,
but
therapeutic
strategies
to
slow
down
AD
pathology
and
symptoms
have
not
yet
been
successful.
While
attention
has
focused
on
neurodegeneration
in
pathogenesis,
recent
decades
provided
evidence
of
importance
microglia,
resident
immune
cells
central
nervous
system.
In
addition,
new
technologies,
including
single-cell
RNA
sequencing,
revealed
heterogeneous
cell
states
microglia
AD.
this
review,
we
systematically
summarize
microglial
response
amyloid-β
tau
tangles,
risk
factor
genes
expressed
microglia.
Furthermore,
discuss
characteristics
protective
that
appear
during
relationship
between
microglia-induced
inflammation
chronic
pain.
Understanding
diverse
roles
will
help
identify
for
Journal of Biotechnology,
Journal Year:
2024,
Volume and Issue:
386, P. 10 - 18
Published: March 20, 2024
Microglia
are
the
resident
macrophages
in
central
nervous
system,
accounting
for
10-15%
of
cell
mass
brain.
Next
to
their
physiological
role
development,
monitoring
neuronal
function
and
maintenance
homeostasis,
microglia
crucial
brain's
immune
defense.
Brain
injury
chronic
neurological
disorders
associated
with
neuroinflammation,
which
activation
is
a
element.
acquire
wide
spectrum
states
diseased
or
injured
brain,
some
neurotoxic.
The
investigation
(patho)physiology
therapeutic
interventions
targeting
neuroinflammation
substantial
challenge.
In
addition
vivo
approaches,
application
vitro
model
systems
has
gained
significant
ground
essential
complement
work.
Primary
cultures
have
proved
be
useful
tool.
offered
opportunity
explore
mechanistic,
molecular
elements
activation,
secretome,
efficacy
treatments
against
neuroinflammation.
As
all
systems,
primary
distinct
strengths
limitations
weighed
when
experiments
designed
data
interpreted.
Here,
we
set
out
provide
succinct
overview
advantages
pitfalls
use
cultures,
instructs
refinement
further
development
this
technique
remain
toolbox
researchers.
Since
there
no
conclusive
therapy
combat
neurotoxicity
linked
acute
brain
neurodegenerative
disorders,
these
research
tools
opportunities.